Hanajiri R, Murata M, Sugimoto K, Murase M, Sakemura R, Goto T, et al. Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection. Bone Marrow Transpl. 2015;50(9):1187–94.

Article  CAS  Google Scholar 

Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116(15):2839–46.

Yoshihara S, Maruya E, Taniguchi K, Kaida K, Kato R, Inoue T, et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transpl. 2012;47(4):508–15.

Spellman S, Bray R, Bronson SR, Haagenson M, Klein J, Flesch S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704–8.

Brittany F, Huang Y, Peedin A, Gergis U. The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies. Bone Marrow Transpl. 2022;57(4):526–31.

Article  Google Scholar 

Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, et al. Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:1392–8.

Article  CAS  Google Scholar 

Everly MJ, Everly JJ, Susskind B, Arend LJ, Alloway RR, Chaudhury PR, et al. Proteasome inhibition reduces donor-specific antibody levels. Transpl Proc. 2009;41(1):105–7.

Article  CAS  Google Scholar 

Miki H, Ozaki S, Tanaka O, Lee E, Takimoto T, Watanabe H, et al. Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma. Int J Hematol. 2009;89:223–6.

Article  PubMed  Google Scholar 

Ibrahim U, Keyzner A. Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation. Hematol Transfus Cell Ther. 2023;45(4):510–2.

Article  PubMed  Google Scholar 

Chang YJ, Xu LP, Wang YU, Zhang XH, Chen H, Chen YH, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transpl. 2020;55(7):1326–36.

Article  CAS  Google Scholar 

Misra MK, Xin JJ, Brown NK, Weidner JG, Upchurch RL, Bishop MR, et al. Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation. HLA Immune Response Genet. 2019;94(3):307–11.

CAS  Google Scholar 

Reverberi R, Reverberi L. Removal kinetics of therapeutic apheresis. Blood Transfus. 2007;5(3):164–74.

PubMed  PubMed Central  Google Scholar 

Zhu J, Wang Q, Liu Y, Dong Y, Liang Z, Yin Y, et al. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific anti-HLA antibody desensitization in haploidentical transplant. Int Immunopharmacol. 2023;120:110299.

Article  CAS  PubMed  Google Scholar 

Spriewald BM, Bach C, Zingsem J, Strobel J, Winkler J, Mackensen A, et al. Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions. Bone Marrow Transpl. 2018;53(6):791–4.

Article  Google Scholar 

Ciurea SO, Lima MD, Cano P, Korbling M, Giralt S, Shpall EJ, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009;88(8):1019–24.

Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, et al. A strategy to reduce donor-specific HLA Abs before allogeneic transplantation. Bone Marrow Transpl. 2014;49:722–4.

Choe H, Gergis U, Phillips A, Hsu JM, Sharma V, Shore TB, et al. Bortezomib and immune globulin desensitization for donor-specific HLA antibodies in haplo-cord stem cell transplantation. Transpl Cell Ther. 2017;23(3):S265.

Google Scholar